Mississippi State Department of Health

COVID-19 Guidance and Information for Healthcare Professionals
Updated August 2023

  [close]

Healthcare Guidance

Guidance, reporting, patient handouts and more from MSDH

Therapeutics

Healthcare Provider Guidance and Resources

Patient Handouts

Vaccination Providers

Reporting COVID-19

COVID-19 Deaths

COVID-19 Therapeutics

Therapeutics currently authorized or approved for the treatment of mild to moderate COVID-19 include the oral antivirals Paxlovid and Lagevrio and the intravenous antiviral Veklury.
Overview of Therapeutics for the Prevention or Treatment of COVID-19 (HHS.gov)

Oral Antivirals

Ordering: The federal government has designed the Healthcare Provider Order Portal (HPOP) for management of COVID-19 therapeutics. Please place your order in HPOP. You will be able to see courses ordered for your site on your HPOP account. If you do not have an HPOP account, please contact C19Therapeutics@msdh.ms.gov

Required reporting:Courses administered (dispensed) and courses available of Paxlovid and Lagevrio should be entered into HPOP by the provider site at least twice per month, on the 15th and last day of the month. Timely and accurate inventory reporting is necessary for federal partners to determine subsequent state allocations.

Resources:

Therapeutics Locator

Use this interactive map to locate a facility that has one of the authorized therapeutics for COVID-19.

Monoclonal Antibody Therapy

There are no monoclonal antibodies currently authorized in the U.S. for the outpatient treatment of COVID-19.

The following monoclonal antibody products are no longer authorized for use in the U.S.:

Evusheld

As of January 26, 2023, Evusheld is no longer authorized for Emergency use for pre-exposure prophylaxis (prevention) of COVID-19.

Remdesivir

Remdesivir has been studied in non-hospitalized patients with mild to moderate COVID-19 who are at high risk of progressing to severe disease and is approved by the FDA for use in both hospitalized and non-hospitalized patients.

Ordering: Remdesivir is commercially available and should be ordered through standard pharmaceutical procurement processes.

Health Facilities

Specimen Collection, Delivery and Reporting

Specimen Reporting

SARS-CoV-2 Virus Strain Surveillance

Map and Directions for Laboratory Dropoff

The Dr. F.E.”ED” Thompson, Jr. Public Health Laboratory Facility is on the State Department of Health's central office campus in Jackson, MS at 350 East Woodrow Wilson Drive, Jackson, 39216.

Local Delivery of Samples: Drop samples off at the rear of the Thompson lab building. Detailed instructions are in our sample shipping guidance.

Dropoff hours: Monday through Friday from 8:00–4:30.

CDC Guidance

Healthcare and EMS

Contact Tracing

More from the CDC

Links referenced on this page
COVID-19 Therapeutics Decision Aid    https://aspr.hhs.gov/COVID-19/Therapeutics/Documents/COVID-Therapeutics-Decision-Aid.pdf
Outpatient Administration Guide for Healthcare Providers    https://www.phe.gov/emergency/events/COVID19/investigation-MCM/Documents/USG-COVID19-Tx-Playbook.pdf
CDC Infection Control Recommendations for Healthcare Professionals During COVID-19    https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html
NIH Clinical Guidelines: Therapies for High-Risk, Nonhospitalized Patients    https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-therapies-for-high-risk-nonhospitalized-patients/
NIH Panel's Statement on Prioritizing the Use of Outpatient Therapies    https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-patient-prioritization-for-outpatient-therapies/
CDC Guidance for Healthcare Personnel with Potential COVID-19 Exposure    https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
Handout: What to Do After You Have Been Tested for COVID-19    http://msdh.ms.gov/msdhsite/index.cfm/14,19334,420,pdf/HCP_C19_After_Your_Test.pdf
Handout: Home Isolation for Individuals with COVID-19    http://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf
Home Isolation for Individuals with COVID-19    http://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf
Molnupiravir fact sheet    https://www.fda.gov/media/155055/download
Paxlovid fact sheet    https://www.fda.gov/media/155051/download
Enrollment and Resources for COVID-19 Vaccination Providers    http://msdh.ms.gov/msdhsite/index.cfm/14,0,71,975,html ok
Updated SARS-CoV-2 Reporting Requirements    http://msdh.ms.gov/page/resources/19837.pdf
Death Reporting Q & A for Medical Examiners, Coroners and Physicians    http://msdh.ms.gov/msdhsite/index.cfm/14,22075,420,694,html ok
CDC Guidance on Certifying COVID-19 Deaths    https://www.cdc.gov/nchs/data/nvss/vsrg/vsrg03-508.pdf
How to get a Mississippi death certificate    http://msdh.ms.gov/msdhsite/index.cfm/31,0,109,809,html ok
Overview of Therapeutics for the Prevention or Treatment of COVID-19 (HHS.gov)    https://aspr.hhs.gov/COVID-19/Therapeutics/Documents/side-by-side-overview.pdf
Healthcare Provider Order Portal    https://idcs-3182013a765344028d81d62323507b48.us-langley-idcs-1.identity.oci.oraclegovcloud.com/ui/v1/signin
C19Therapeutics@msdh.ms.gov    mailto:C19Therapeutics@msdh.ms.gov
PAXLOVID Patient Eligibility Screening Checklist Tool for Prescribers    https://www.fda.gov/media/158165/download
Paxlovid Resources from Pfizer.com    https://www.pfizer.com/news/press-release/press-release-detail/pfizers-novel-covid-19-oral-antiviral-treatment-candidate
Paxlovid Package Insert    https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/217188s000lbl.pdf
Paxlovid fact sheet for healthcare providers    https://www.fda.gov/media/155050/download
Paxlovid fact sheet for patients/caregivers    https://www.fda.gov/media/155051/download
Lagevrio resources from Merck.com    https://www.merck.com/news/merck-and-ridgebacks-molnupiravir-receives-u-s-fda-emergency-use-authorization-for-the-treatment-of-high-risk-adults-with-mild-to-moderate-covid-19/
Lagevrio fact sheet for healthcare providers    https://www.fda.gov/media/155054/download
Lagevrio fact sheet for patients/caregivers    https://www.fda.gov/media/155055/download
View this locator full-screen    https://app.powerbigov.us/view?r=eyJrIjoiMzkxZDYzNmUtYTg3Ni00YzljLWFmODctMDg1Njc5MzE2MjU1IiwidCI6IjU1OTA0MmRjLThiZjAtNGQ4Ni05ZmMwLWZiZjRjNzUwM2M3OSJ9
NIH Treatment Guidelines    https://www.covid19treatmentguidelines.nih.gov/therapies/statement-on-therapies-for-high-risk-nonhospitalized-patients/
Long-term care facility guidance documents    http://msdh.ms.gov/msdhsite/index.cfm/14,21866,420.html ok
Mississippi COVID-19 System of Care    http://msdh.ms.gov/msdhsite/index.cfm/44,0,397,881,html ok
COVID-19 Specimen Collection    http://msdh.ms.gov/msdhsite/index.cfm/14,8501,420,pdf/COVID-19_Specimen_Collection.pdf
COVID-19 Lab Requisition Form    http://msdh.ms.gov/msdhsite/index.cfm/14,8500,420,pdf/COVID-19_Laboratory_Requisition.pdf
COVID-19 Refrigerated Specimen Packaging    http://msdh.ms.gov/msdhsite/index.cfm/14,8499,420,pdf/COVID-19_Refrigerated_Specimen_Packaging.pdf
COVID-19 Frozen Specimen Packaging    http://msdh.ms.gov/msdhsite/index.cfm/14,8498,420,pdf/COVID-19_Frozen_Specimen_Packaging.pdf
COVID-19 Specimen Transport and Delivery    http://msdh.ms.gov/msdhsite/index.cfm/14,8497,420,pdf/COVID-19_Specimen_Transport.pdf
COVID-19 Specimen Reporting    http://msdh.ms.gov/msdhsite/index.cfm/14,8496,420,pdf/COVID-19_Specimen_Reporting.pdf
MPHL Fax Reporting Agreement    http://msdh.ms.gov/msdhsite/index.cfm/14,8495,420,pdf/MPHL_Fax_Reporting_Agreement.pdf
COVID-19 Enhanced Surveillance Submission Recommendations    http://msdh.ms.gov/msdhsite/index.cfm/14,13625,420,pdf/MSDH_COVID-19_Surveillance.pdf
SARS-CoV-2 Enhanced Surveillance Submission Requisition    http://msdh.ms.gov/msdhsite/_static/resources/14128.pdf
Home Care Guidance    https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html
Discontinuation of Home Isolation for Persons with COVID-19    https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html
Healthcare Infection Control Guidance    https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control.html
Clinical Care Guidance    https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
Healthcare Personnel with Potential COVID-19 Exposure Guidance    https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html
Inpatient Obstetric Healthcare Guidance    https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcare-guidance.html
Guidance for EMS    https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-for-ems.html
Contact Tracing Information and Guidance    https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html
Collection and Submission of Postmortem Specimens from Deceased Persons with Confirmed or Suspected COVID-19    https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-postmortem-specimens.html
All CDC guidance for healthcare professionals    https://www.cdc.gov/coronavirus/2019-ncov/hcp/
Resources referenced
Handout: What to Do After You Have Been Tested for COVID-19    https://msdh.ms.gov/msdhsite/index.cfm/14,19334,420,pdf/HCP_C19_After_Your_Test.pdf ok
Handout: Home Isolation for Individuals with COVID-19    https://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf ok
Home Isolation for Individuals with COVID-19    https://msdh.ms.gov/msdhsite/index.cfm/14,9915,420,pdf/HCP_C19_self_isolate.pdf ok
Updated SARS-CoV-2 Reporting Requirements    https://msdh.ms.gov/page/resources/19837.pdf ok
COVID-19 Specimen Collection    https://msdh.ms.gov/msdhsite/index.cfm/14,8501,420,pdf/COVID-19_Specimen_Collection.pdf ok
COVID-19 Lab Requisition Form    https://msdh.ms.gov/msdhsite/index.cfm/14,8500,420,pdf/COVID-19_Laboratory_Requisition.pdf ok
COVID-19 Refrigerated Specimen Packaging    https://msdh.ms.gov/msdhsite/index.cfm/14,8499,420,pdf/COVID-19_Refrigerated_Specimen_Packaging.pdf ok
COVID-19 Frozen Specimen Packaging    https://msdh.ms.gov/msdhsite/index.cfm/14,8498,420,pdf/COVID-19_Frozen_Specimen_Packaging.pdf ok
COVID-19 Specimen Transport and Delivery    https://msdh.ms.gov/msdhsite/index.cfm/14,8497,420,pdf/COVID-19_Specimen_Transport.pdf ok
COVID-19 Specimen Reporting    https://msdh.ms.gov/msdhsite/index.cfm/14,8496,420,pdf/COVID-19_Specimen_Reporting.pdf ok
MPHL Fax Reporting Agreement    https://msdh.ms.gov/msdhsite/index.cfm/14,8495,420,pdf/MPHL_Fax_Reporting_Agreement.pdf ok
COVID-19 Enhanced Surveillance Submission Recommendations    https://msdh.ms.gov/msdhsite/index.cfm/14,13625,420,pdf/MSDH_COVID-19_Surveillance.pdf ok
SARS-CoV-2 Enhanced Surveillance Submission Requisition    https://msdh.ms.gov/msdhsite/_static/resources/14128.pdf ok

Find this page at https://msdh.ms.gov/page/14,0,420,694.html

print  close